MEKICS CO., Ltd (KOSDAQ:058110)
South Korea · Delayed Price · Currency is KRW 3,235.00
+245.00 (8.19%)
At close: Apr 17, 2026
MEKICS CO., Revenue
In the year 2025, MEKICS CO., had annual revenue of 11.29B KRW, down -0.71%. MEKICS CO., had revenue of 3.23B in the quarter ending December 31, 2025, a decrease of -11.23%.
Revenue
11.29B
Revenue Growth
-0.71%
P/S Ratio
4.44
Revenue / Employee
163.59M
Employees
69
Market Cap
50.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.29B | -81.25M | -0.71% |
| Dec 31, 2024 | 11.37B | -1.89B | -14.27% |
| Dec 31, 2023 | 13.26B | -15.49B | -53.88% |
| Dec 31, 2022 | 28.75B | -20.54B | -41.67% |
| Dec 31, 2021 | 49.30B | -18.76B | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 102.75B |
| JPI Healthcare | 48.47B |
| CU Medical Systems | 48.22B |
| Hironic | 32.09B |
| Remed | 24.50B |
| Neofect | 16.05B |
| Noul Co.,Ltd. | 5.12B |